Fortress Biotech Announces Receipt of Notice of Option Exercise from AstraZeneca to Fully Acquire Caelum Biosciences, a Company Founded by Fortress Biotech Sep 29, 2021
Mustang Bio Announces MB-101 (IL13Rα2‐targeted CAR T cells) Scientific Presentations at Upcoming Virtual Conferences Sep 28, 2021
Checkpoint Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference Sep 22, 2021